Hostname: page-component-cd9895bd7-8ctnn Total loading time: 0 Render date: 2024-12-18T14:49:47.228Z Has data issue: false hasContentIssue false

S33-01 - Modulation of Ligand Gated Ion Channels by Antidepressants

Published online by Cambridge University Press:  17 April 2020

R. Rupprecht
Affiliation:
LMU Munich, Munich, Germany
C. Nothdurfter
Affiliation:
LMU Munich, Munich, Germany
S. Tanasic
Affiliation:
LMU Munich, Munich, Germany
G. Rammes
Affiliation:
LMU Munich, Munich, Germany

Abstract

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.

The classical mechanisms of action of antidepressants suggest that they act through inhibition of monoamine transporters. There is evidence that antipressants indirectly modulate GABA-A receptors through neurosteroids. We showed that antidepressants may also directly modulate the function of the serotonin type 3 (5-HT3) receptor in an allosteric fashion. This non-competitive inhibition of receptor function occurred with different classes of antidepressants including tricyclic antidepressants, SSRIs and NARIs. Moreover, these antidepressants were differentially accumulated in lipid rafts. Their concentartions in lipid rafts were related to their ability to allosterically modulate this ligand gated ion channel. However, lipid raft integrity was not a prerequisite for the allosteric modulation of this ion channel by antidepressants. Morover, differential results were observed with regard to NMDA and GABA-A receptors. Our data show that the allosteric modulation of ligand gated ion channels is an underestimated pharmacologcical principle which challenges the concept of target specificty of antidepressants for monoamine transporters.

Type
Novel mechanisms of action of antidepressants
Copyright
Copyright © European Psychiatric Association 2010
Submit a response

Comments

No Comments have been published for this article.